Idiopathic pulmonary arterial hypertension. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Pulmonary Artery Lung Myocytes, Smooth Muscle Muscle, Smooth, Vascular Cells, Cultured Heart Ventricles Endothelium, Vascular Endothelial Cells Heart Septum Kidney

Organisms2

Rats, Sprague-Dawley Rats, Inbred SHR

Diseases40

Hypertension, Pulmonary Pulmonary Veno-Occlusive Disease Hypertrophy, Right Ventricular Scleroderma, Systemic Ventricular Dysfunction, Right Hypertension Eisenmenger Complex Connective Tissue Diseases Hypertension, Portal Hypertension, Renal Idiopathic Pulmonary Fibrosis Anoxia Disease Models, Animal Hypertension, Renovascular Telangiectasia, Hereditary Hemorrhagic Heart Defects, Congenital Pregnancy Complications, Cardiovascular Pulmonary Embolism Chronic Disease Hypertension, Malignant Disease Progression Dyspnea Scoliosis Anticipation, Genetic Pulmonary Fibrosis Genetic Predisposition to Disease Ventricular Remodeling Heart Failure Arthritis, Juvenile Vascular Diseases Lung Diseases, Interstitial Purpura, Thrombocytopenic, Idiopathic Hypertrophy Scleroderma, Limited Airway Remodeling Hypertension, Pregnancy-Induced Thromboembolism Ventricular Dysfunction Mixed Connective Tissue Disease Hypertrophy, Left Ventricular

Chemicals and Drugs51

Bone Morphogenetic Protein Receptors, Type II Epoprostenol Monocrotaline Antihypertensive Agents Iloprost Sulfones Sulfonamides Vasodilator Agents Purines Carbolines Phosphodiesterase 5 Inhibitors Receptors, Endothelin Piperazines Phenylpropionates Prostaglandins I Dexfenfluramine Prostaglandins, Synthetic Phosphodiesterase Inhibitors Cyclic Nucleotide Phosphodiesterases, Type 5 Receptor, Endothelin A Pyridazines Natriuretic Peptide, Brain Receptor, Endothelin B Isoxazoles Smad8 Protein 3',5'-Cyclic-GMP Phosphodiesterases Thiophenes Endothelin-1 Poisons Nitric Oxide Biological Markers Activin Receptors, Type II Smad Proteins, Receptor-Regulated TGF-beta Superfamily Proteins Diuretics Appetite Depressants Bone Morphogenetic Protein Receptors Nitric Oxide Synthase Type III Calcium Channel Blockers Serotonin Plasma Membrane Transport Proteins Endothelium-Dependent Relaxing Factors Lisuride Prostaglandins Pyrimidines Kv1.5 Potassium Channel Fenfluramine Renin Spironolactone Smad1 Protein Bone Morphogenetic Protein Receptors, Type I Chlorobenzoates

Analytical, Diagnostic and Therapeutic Techniques and Equipment41

Cardiac Catheterization Lung Transplantation Exercise Test Treatment Outcome Drug Therapy, Combination Severity of Illness Index Retrospective Studies Blood Pressure Case-Control Studies Follow-Up Studies Prospective Studies Survival Rate Disease Models, Animal Risk Factors Heart-Lung Transplantation Administration, Inhalation Echocardiography Echocardiography, Doppler Prognosis Administration, Oral Cohort Studies Prevalence Cardiac Output Respiratory Function Tests Predictive Value of Tests Double-Blind Method Drug Substitution Kaplan-Meier Estimate Endpoint Determination Analysis of Variance Risk Assessment Heart Rate Pulmonary Diffusing Capacity Blood Pressure Determination Early Diagnosis Fatal Outcome Pulmonary Gas Exchange Angiography Catheterization, Swan-Ganz Blood Pressure Monitoring, Ambulatory Drug Administration Schedule

Phenomena and Processes26

Hemodynamics Pulmonary Wedge Pressure Exercise Tolerance Vascular Resistance Blood Pressure Pulmonary Circulation Arterial Pressure Ventricular Function, Right Time Factors Walking Vasoconstriction Cardiac Output Ventricular Pressure Cell Proliferation Anticipation, Genetic Systole Genetic Predisposition to Disease Ventricular Remodeling Dose-Response Relationship, Drug Vasodilation Heart Rate Pulmonary Diffusing Capacity Signal Transduction Airway Remodeling Mutation Pulmonary Gas Exchange

Disciplines and Occupations1

Pulmonary Medicine

Anthropology, Education, Sociology and Social Phenomena2

Walking Quality of Life

Humanities1

Quality of Life

Information Science3

Survival Rate Prevalence Fatal Outcome

Health Care18

Treatment Outcome Severity of Illness Index Retrospective Studies Case-Control Studies Follow-Up Studies Prospective Studies Survival Rate Risk Factors Cohort Studies Prevalence Predictive Value of Tests Double-Blind Method Drug Substitution Kaplan-Meier Estimate Analysis of Variance Risk Assessment Age Factors Fatal Outcome

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care Geographicals

Hypertension, Pulmonary Pulmonary Artery Bone Morphogenetic Protein Receptors, Type II Epoprostenol Monocrotaline Antihypertensive Agents Iloprost Pulmonary Veno-Occlusive Disease Hypertrophy, Right Ventricular Sulfones Scleroderma, Systemic Sulfonamides Vasodilator Agents Ventricular Dysfunction, Right Purines Hypertension Hemodynamics Pulmonary Wedge Pressure Exercise Tolerance Carbolines Lung Myocytes, Smooth Muscle Cardiac Catheterization Vascular Resistance Lung Transplantation Exercise Test Phosphodiesterase 5 Inhibitors Treatment Outcome Eisenmenger Complex Drug Therapy, Combination Severity of Illness Index Retrospective Studies Blood Pressure Case-Control Studies Receptors, Endothelin Connective Tissue Diseases Pulmonary Circulation Arterial Pressure Follow-Up Studies Piperazines Muscle, Smooth, Vascular Prospective Studies Phenylpropionates Hypertension, Portal Survival Rate Hypertension, Renal Idiopathic Pulmonary Fibrosis Ventricular Function, Right Anoxia Prostaglandins I Dexfenfluramine Prostaglandins, Synthetic Phosphodiesterase Inhibitors Cells, Cultured Cyclic Nucleotide Phosphodiesterases, Type 5 Receptor, Endothelin A Disease Models, Animal Pyridazines Hypertension, Renovascular Telangiectasia, Hereditary Hemorrhagic Heart Defects, Congenital Risk Factors Time Factors Heart-Lung Transplantation Administration, Inhalation Natriuretic Peptide, Brain Receptor, Endothelin B Isoxazoles Smad8 Protein Echocardiography Walking 3',5'-Cyclic-GMP Phosphodiesterases Thiophenes Echocardiography, Doppler Endothelin-1 Pregnancy Complications, Cardiovascular Prognosis Pulmonary Embolism Poisons Rats, Sprague-Dawley Administration, Oral Nitric Oxide Chronic Disease Vasoconstriction Hypertension, Malignant Heart Ventricles Cohort Studies Endothelium, Vascular Prevalence Cardiac Output Ventricular Pressure Endothelial Cells Biological Markers Respiratory Function Tests Activin Receptors, Type II Smad Proteins, Receptor-Regulated Disease Progression Dyspnea Cell Proliferation TGF-beta Superfamily Proteins

No FAQ available that match "idiopathic pulmonary arterial hypertension"